 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Arcutis Biotherapeutics Inc. (ARQT)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-08-03 Sale | 2020-08-05 5:11 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,800 | $25.63 | $71,764 | 159,992 (Indirect Direct) | View |
| 2020-09-01 Sale | 2020-09-02 11:48 am | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,200 | $24.38 | $53,643 | 176,178 (Indirect Direct) | View |
| 2020-09-29 Sale | 2020-10-01 9:00 pm | Arcutis Biotherapeutics Inc. | ARQT | Smither John W CFO | 1,750 | $30 | $52,500 | 98,715 (Indirect Direct) | View |
| 2020-09-29 Sale | 2020-10-01 9:01 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W CTO | 15,000 | $30 | $450,000 | 264,279 (Indirect Direct) | View |
| 2020-09-29 Sale | 2020-10-01 9:02 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 3,000 | $30 | $90,000 | 566,928 (Indirect Direct) | View |
| 2020-09-01 Sale(A) | 2020-10-05 9:12 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,200 | $24.38 | $53,643 | 176,178 (Indirect Direct) | View |
| 2020-10-01 Sale | 2020-10-05 9:13 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,200 | $27.65 | $60,829 | 177,400 (Indirect Direct) | View |
| 2020-10-02 Purchase | 2020-10-06 5:23 pm | Arcutis Biotherapeutics Inc. | ARQT | SILVERSTEIN JONATHAN Director 10% Owner | 496,000 | $25 | $12,400,000 | 902,286 (Indirect) | View |
| 2020-10-02 Purchase | 2020-10-06 5:27 pm | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner | 496,000 | $25 | $12,400,000 | 902,286 (Indirect) | View |
| 2020-11-02 Sale | 2020-11-04 4:33 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,200 | $18.27 | $40,186 | 178,622 (Indirect Direct) | View |
| 2020-12-01 Sale | 2020-12-03 7:40 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,200 | $25.98 | $57,155 | 179,844 (Indirect Direct) | View |
| 2020-12-14 Sale | 2020-12-16 3:14 pm | Arcutis Biotherapeutics Inc. | ARQT | Smither John W CFO | 5,250 | $30 | $157,500 | 94,965 (Indirect Direct) | View |
| 2020-12-14 Sale | 2020-12-16 3:15 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W CTO | 15,000 | $30 | $450,000 | 250,533 (Indirect Direct) | View |
| 2021-01-04 Sale | 2021-01-06 1:16 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,200 | $27.82 | $61,215 | 181,896 (Indirect Direct) | View |
| 2021-01-05 Sale | 2021-01-07 2:39 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 3,000 | $30 | $90,000 | 566,928 (Indirect Direct) | View |
| 2021-01-05 Sale(A) | 2021-01-07 3:13 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 10,000 | $28.08 | $280,754 | 568,323 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-02-27 Option Award | 2020-03-03 9:06 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W CTO | 9,000 | $0 | 12,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:06 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W CTO | 12,000 | $27.61 | 12,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:08 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | SILVERSTEIN JONATHAN Director 10% Owner | 24,000 | $27.61 | 24,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:09 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W CFO | 9,000 | $0 | 12,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:09 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W CFO | 12,000 | $27.61 | 12,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:10 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. VP | 9,000 | $0 | 27,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:10 pm | N/A 2030-03-27 | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. VP | 27,000 | $27.61 | 27,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:12 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 29,000 | $0 | 65,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:12 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 65,000 | $27.61 | 65,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:13 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Chief Medical Officer | 9,000 | $0 | 12,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:13 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Chief Medical Officer | 12,000 | $27.61 | 12,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-04 4:42 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Sun Ricky Director | 24,000 | $27.61 | 24,000 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-16 6:04 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Chief Medical Officer | 6,110 | $0.5802 | 36,660 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-16 6:04 pm | N/A 2028-06-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Chief Medical Officer | 6,110 | $0.5802 | 36,660 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 6:05 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 59,481 | $1.6806 | 158,492 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 6:05 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 59,481 | $1.6806 | 158,492 (Direct) | View |
| 2020-05-01 Option Award | 2020-05-01 8:09 pm | N/A 2030-05-01 | Arcutis Biotherapeutics Inc. | ARQT | Gilbert Halley E Director | 37,500 | $26 | 37,500 (Direct) | View |
| 2020-06-11 Exercise | 2020-06-15 3:15 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W CFO | 14,875 | $1.6806 | 110,080 (Direct) | View |
| 2020-06-11 Exercise | 2020-06-15 3:15 pm | N/A 2029-05-14 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W CFO | 14,875 | $1.6806 | 110,080 (Direct) | View |
| 2020-08-03 Option Award | 2020-08-05 5:02 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 33,500 | $0 | 320,000 (Direct) | View |
| 2020-08-03 Option Award | 2020-08-05 5:02 pm | N/A 2030-08-03 | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 320,000 | $25.89 | 320,000 (Direct) | View |
| 2020-08-03 Exercise | 2020-08-05 5:11 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,733 | $1.68 | 159,992 (Direct) | View |
| 2020-08-03 Exercise | 2020-08-05 5:11 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 67 | $1.68 | 159,992 (Direct) | View |
| 2020-08-03 Exercise | 2020-08-05 5:11 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,733 | $1.68 | 159,992 (Direct) | View |
| 2020-08-03 Exercise | 2020-08-05 5:11 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 67 | $1.68 | 159,992 (Direct) | View |
| 2020-08-14 Exercise | 2020-08-18 4:12 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 6,110 | $0.5802 | 30,550 (Direct) | View |
| 2020-08-14 Exercise | 2020-08-18 4:12 pm | N/A 2028-06-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 6,110 | $0.5802 | 30,550 (Direct) | View |
| 2020-08-18 Exercise | 2020-08-19 5:48 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 5,076 | $1.68 | 13,667 (Direct) | View |
| 2020-08-18 Exercise | 2020-08-19 5:48 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 5,076 | $1.68 | 13,667 (Direct) | View |
| 2020-08-20 Exercise | 2020-08-21 2:19 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 5,000 | $1.68 | 44,982 (Direct) | View |
| 2020-08-20 Exercise | 2020-08-21 2:19 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 5,000 | $1.68 | 44,982 (Direct) | View |
| 2020-09-01 Exercise | 2020-09-02 11:48 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,200 | $1.68 | 176,178 (Direct) | View |
| 2020-09-01 Exercise | 2020-09-02 11:48 am | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,200 | $1.68 | 176,178 (Direct) | View |
| 2020-09-15 Exercise | 2020-09-16 5:57 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,222 | $0.5802 | 29,328 (Direct) | View |
| 2020-09-15 Exercise | 2020-09-16 5:57 pm | N/A 2028-06-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,222 | $0.5802 | 29,328 (Direct) | View |
| 2020-09-29 Exercise | 2020-10-01 9:00 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W CFO | 500 | $1.6806 | 98,715 (Direct) | View |
| 2020-09-29 Exercise | 2020-10-01 9:00 pm | N/A 2029-05-14 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W CFO | 500 | $1.6806 | 98,715 (Direct) | View |
| 2020-09-29 Exercise | 2020-10-01 9:02 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 3,000 | $1.6806 | 566,928 (Direct) | View |
| 2020-09-29 Exercise | 2020-10-01 9:02 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 3,000 | $1.6806 | 566,928 (Direct) | View |
| 2020-09-01 Exercise | 2020-10-05 9:12 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,028 | $1.68 | 176,178 (Direct) | View |
| 2020-09-01 Exercise | 2020-10-05 9:12 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,172 | $1.68 | 176,178 (Direct) | View |
| 2020-09-01 Exercise | 2020-10-05 9:12 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,028 | $1.68 | 176,178 (Direct) | View |
| 2020-09-01 Exercise | 2020-10-05 9:12 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,172 | $1.68 | 176,178 (Direct) | View |
| 2020-10-01 Exercise | 2020-10-05 9:13 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,810 | $1.68 | 177,400 (Direct) | View |
| 2020-10-01 Exercise | 2020-10-05 9:13 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 390 | $1.68 | 177,400 (Direct) | View |
| 2020-10-01 Exercise | 2020-10-05 9:13 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,810 | $1.68 | 177,400 (Direct) | View |
| 2020-10-01 Exercise | 2020-10-05 9:13 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 390 | $1.68 | 177,400 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 2:06 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,222 | $0.5802 | 28,106 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 2:06 pm | N/A 2028-06-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,222 | $0.5802 | 28,106 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 2:06 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 7,500 | $6.52 | 152,443 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 2:06 pm | N/A 2029-10-28 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 7,500 | $6.52 | 152,443 (Direct) | View |
| 2020-10-22 Exercise | 2020-10-23 1:27 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 2,695 | $6.52 | 149,748 (Direct) | View |
| 2020-10-22 Exercise | 2020-10-23 1:27 pm | N/A 2029-10-28 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 2,695 | $6.52 | 149,748 (Direct) | View |
| 2020-10-26 Exercise | 2020-10-27 2:03 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 2,668 | $6.52 | 147,080 (Direct) | View |
| 2020-10-26 Exercise | 2020-10-27 2:03 pm | N/A 2029-10-28 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 2,668 | $6.52 | 147,080 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-04 4:33 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 391 | $1.68 | 178,622 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-04 4:33 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,809 | $1.68 | 178,622 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-04 4:33 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 391 | $1.68 | 178,622 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-04 4:33 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,809 | $1.68 | 178,622 (Direct) | View |
| 2020-11-02 Option Award | 2020-11-04 4:34 pm | N/A 2030-11-02 | Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director | 37,500 | $18.72 | 37,500 (Direct) | View |
| 2020-11-12 Exercise | 2020-11-13 11:57 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,222 | $0.5802 | 26,884 (Direct) | View |
| 2020-11-12 Exercise | 2020-11-13 11:57 am | N/A 2028-06-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,222 | $0.5802 | 26,884 (Direct) | View |
| 2020-12-01 Exercise | 2020-12-03 7:40 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 390 | $1.68 | 179,844 (Direct) | View |
| 2020-12-01 Exercise | 2020-12-03 7:40 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,810 | $1.68 | 179,844 (Direct) | View |
| 2020-12-01 Exercise | 2020-12-03 7:40 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 390 | $1.68 | 179,844 (Direct) | View |
| 2020-12-01 Exercise | 2020-12-03 7:40 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,810 | $1.68 | 179,844 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-16 3:14 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,222 | $0.5802 | 25,662 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-16 3:14 pm | N/A 2028-06-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,222 | $0.5802 | 25,662 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-16 3:14 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W CFO | 1,500 | $1.6806 | 94,965 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-16 3:14 pm | N/A 2029-05-14 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W CFO | 1,500 | $1.6806 | 94,965 (Direct) | View |
| 2021-01-04 Exercise | 2021-01-06 1:16 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 391 | $1.6806 | 181,896 (Direct) | View |
| 2021-01-04 Exercise | 2021-01-06 1:16 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,809 | $1.6806 | 181,896 (Direct) | View |
| 2021-01-04 Exercise | 2021-01-06 1:16 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 391 | $1.6806 | 181,896 (Direct) | View |
| 2021-01-04 Exercise | 2021-01-06 1:16 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,809 | $1.6806 | 181,896 (Direct) | View |
| 2021-01-05 Exercise | 2021-01-07 2:39 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 3,000 | $1.6806 | 566,928 (Direct) | View |
| 2021-01-05 Exercise | 2021-01-07 2:39 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 3,000 | $1.6806 | 566,928 (Direct) | View |
| 2021-01-05 Exercise | 2021-01-07 3:13 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 10,000 | $1.6806 | 568,323 (Direct) | View |
| 2021-01-05 Exercise | 2021-01-07 3:13 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 10,000 | $1.6806 | 568,323 (Direct) | View |
| 2021-01-12 Exercise | 2021-01-14 11:11 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,222 | $0.5802 | 24,440 (Direct) | View |
| 2021-01-12 Exercise | 2021-01-14 11:11 am | N/A 2028-06-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,222 | $0.5802 | 24,440 (Direct) | View |